Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

IVD Raw Materials Market Forecast: What Market Value Is Expected By 2030?

The market for in vitro diagnostic raw materials has experienced robust expansion recently. Projections indicate a rise from $27.47 billion in 2025 to $30.16 billion in 2026, reflecting a compound annual growth rate of 9.8%. This upward trajectory in the historical period has been fueled by several key factors, including a greater volume of clinical diagnostic tests being performed, a higher uptake of immunoassay technologies, the broader application of molecular diagnostics, an increasing need for detecting diseases at early stages, and the well-established use of enzymes and antibodies within in vitro diagnostic kits.

The market for in-vitro diagnostic (IVD) raw materials is poised for substantial expansion in the upcoming years, projecting a reach of $43.76 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.8%. This anticipated growth trajectory over the forecast period is largely propelled by several key factors including the escalating incidence of both chronic and infectious diseases, augmented investments aimed at enhancing precision diagnostics, the expanding utilization of point-of-care testing solutions, a surge in biopharmaceutical research and development endeavors, and a discernible increase in the demand for bespoke IVD raw materials. Significant market trends anticipated within this timeframe encompass a heightened demand for diagnostic reagents characterized by exceptional purity levels, an increasing embrace of recombinant antibodies and proteins in IVD manufacturing, a broader application of materials for molecular diagnostics, a heightened emphasis on ensuring superior quality and consistent batch production, and strategic efforts toward diversifying the supply chain for essential IVD components.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

IVD Raw Materials Market Demand Drivers: What Is Fueling Industry Growth?

The expanding incidence of infectious diseases is poised to be a significant catalyst for the advancement of the IVD raw materials market. Infectious diseases, defined as ailments stemming from pathogenic microorganisms capable of transmission between individuals or other life forms, are becoming more widespread due to accelerating urbanization. This urban growth exacerbates disease transmission through heightened population density and places considerable strain on existing sanitation systems and healthcare facilities. Crucially, the components used in in-vitro diagnostics are instrumental in the fight against infectious diseases, facilitating the creation of precise diagnostic tools essential for early identification and proficient disease control. A notable illustration of this trend, as reported by the Centers for Disease Control and Prevention in March 2024, is the increase in tuberculosis cases within the United States, climbing from 8,320 in 2022 to 9,615 in 2023, marking an escalation of 1,295 instances. Consequently, the escalating rate of infectious diseases directly fuels the expansion of the IVD raw materials sector.

IVD Raw Materials Market Segments: Where Are The Largest Growth Opportunities?

The ivd raw materials market covered in this report is segmented –

1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

IVD Raw Materials Market Innovation Trends: Which Developments Are Transforming The Industry?

In the realm of In Vitro Diagnostic (IVD) raw materials, leading corporations are channeling efforts into pioneering sophisticated offerings, specifically IVD production plants, with the dual aims of bolstering local diagnostic capacities and fostering healthcare autonomy. An IVD production facility is engineered for the conception, fabrication, and rigorous quality assurance of diagnostic tools and apparatus employed in analyzing bodily samples ex vivo to identify ailments and health states. Illustrating this trend, in January of 2024, Colexa Biosensor Limited, a Nigerian health innovation firm, joined forces with Codix Pharma Limited, a fellow Nigerian pharmaceutical entity, to inaugurate the inaugural in vitro diagnostics manufacturing establishment in Sub-Saharan Africa, situated in Lagos. This venture, responsible for manufacturing the onpoint blood glucose meter and accompanying strips, marks a pivotal advancement for healthcare across the African continent, specifically targeting the escalating incidence of diabetes and enhancing the accessibility of diagnostic services. The plant possesses an initial production output of 3.6 million units per annum, with a scalable capacity reaching up to 10.8 million units, and its immediate strategic objective is to satisfy the diagnostic needs within West Africa.

IVD Raw Materials Market Major Participants And Competitive Dynamics

Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

Access The Complete IVD Raw Materials Market Report:

https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

IVD Raw Materials Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the IVD raw materials market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model